Investors - Press Releases
<< Back |
New Studies Shed Light on Opioid-Related Drug Interactions
In a study published in the November issue of the
"With MedWise Science, we can identify who has a higher risk of negative outcomes due to drug interactions," said TRHC Chairman and CEO
A separate study in the
"Genetic analysis brings personalization and precision to the center of medication safety," said
To learn more about TRHC's peer-reviewed publications, visit us online here.
About
View original content to download multimedia:https://www.prnewswire.com/news-releases/new-studies-shed-light-on-opioid-related-drug-interactions-301441342.html
SOURCE
TRHC Media Contact: Anthony Mirenda, amirenda@trhc.com, 908-380-2143; TRHC Investors: Frank Sparacino, fsparacino@trhc.com, 866.648.2767